Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Improving Cervical Cancer Prevention Among HIV-Infected Women Using Novel HPV Based Biomarker Assays

NCT02247999 is registered in ClinicalTrials.gov with National Cancer Institute (NCI) as lead sponsor.

NCT NCT02247999
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02247999 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Improving Cervical Cancer Prevention Among HIV-Infected Women Using Novel HPV Based Biomarker Assays
Lead sponsor
National Cancer Institute (NCI)
Phase
Observational
Overall status
Completed
Start date
November 28, 2012
Completion date
October 8, 2020
Enrollment
1,000 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

biomarkers, cervical cancer, cervical intraepithelial neoplasia, hiv/aids, hpv